medicine – Soliton Solutions PR

Press Release: Staymed Mixer Allows For On Demand Creation of A-Concentrate From Powder Tailored For Patients Needs

Johny Krahbichler — Tue, 26 Apr 2022 13:21:44 +0000

Soliton solutions PR - Tech trade show exhibition specialists

The industry standard for dialysis using B-concentrate is to deliver it by powder and create the dialysis fluid on-demand at hospitals. Unfortunately that isn’t the case with A-Concentrate. Which means huge shipping costs and troublesome handling.

Staymed has come up with a revolutionary mixer that solves this problem. It accomplishes this by using a special membrane to separate and eventually mix RO-water and powder containing the necessary ingredients needed for A-Concentrate..

So what does this mean? It means there’s no longer a need to transport heavy containers of pre-mixed A-Concentrate with an expiration date. Making it easier for medical personnel to perform dialysis on demand. Nurses will no longer have to carry heavy containers of A-Concentrate, doctors can tailor the fluid as they see fit right before treatment, and of course storage space and storage requirements such as temperature are reduced an incredible amount.

But more importantly with the Staymed system the carbon footprint of dialysis would be reduced up to 70%. With only the need to transport the powder bags the total weight of shipments will be reduced substantially. In addition to this hospitals no longer need to worry about expiration dates of the A-concentrate because the powders have an almost infinite shelf-life.

Another aspect of this is that the Staymed solution can be used in hard to reach areas where it was previously very difficult to transport A-concentrate to.

The potential market size for this is 1.170 Mio € globally – based on 390 Mio treatments pa. The market potential only in Europe is 470 Mio €. Currently Staymed is looking for partners and investors to help bring this life saving solution to market as soon as possible.

Staymed holds a patent for their solution and has also built a working prototype which you can see demoed in the below video.

###

Staymed AB is a med-tech startup based in Sweden and founded by inventor Per-Olov Carlsson in cooperation with patent attorneys Erik Krahbichler and Pär Hjalmarsson. They hope to revolutionize the dialysis market with A-Concentrate the same way that has been done with B-Concentrate..

https://staymed.se/

The post Press Release: Staymed Mixer Allows For On Demand Creation of A-Concentrate From Powder Tailored For Patients Needs appeared first on Soliton Solutions PR.

[Press Release] Emerald Corp Is Pioneering The Liquid Supplement Market

Johny Krahbichler — Wed, 03 Feb 2021 14:05:17 +0000

Soliton solutions PR - Tech trade show exhibition specialists

[New York 2021-02-03] The Emerald Corp, an Herbal Supplements manufacturer based in New York State, has focused their recent efforts on new innovations in the supplement space.

Emerald entered the growing CBD market in 2018 and has spent the past three years broadening their product offering by combining popular cannabinoids like CBD and CBG with acclaimed herbal supplements to create a wide range of liquid supplements. In their GMP Certified Clean Room Facility, Emerald supplies hundreds of companies with White Label products such as CBD shots, CBD Topicals, CBD Edibles, CBD Tinctures and more. To keep pace with the constantly evolving CBD industry, Emerald Corp has set out to pioneer the Liquid Supplement market with a wide range of sublingual products.

Their team of R&D’s led by their head chemist Dr. Talha Parveez, PhD, have created a wide range of liquid supplements utilizing CBD as well as popular ingredients like Ashwaghanda, Turmeric, Arnica and many more. With sights set on emerging markets, Emerald has launched branded liquid supplement products in popular categories like Functional Mushrooms, and Apple Cider Vinegar.

Why Liquid Supplements?

Liquid Supplements fill a major void in the daily supplement market. Giving customers the means to take a 1-2mL dropper sized dose of a liquid supplement opposed to a 12oz shake or a pill or capsule gives an added layer of convenience and is extremely attractive to consumers. Aside from convenience, Emerald has made major strides in advanced emulsion techniques to deliver supplements directly into the lymphatic system with lipid-based carrier oils like MCT and Hempseed Oil. In simple, liquid supplements that are administered underneath the tongue are delivered directly into the bloodstream. This offers a faster acting and longer lasting effect in comparison to edible products like gummies or pills that will be delivered through the digestive track and excreted.

Emerald believes that CBD oil has begun to refamiliarize consumers with liquid based supplements. They add a variety of natural flavors to make these supplements enjoyable to take. CBD is commonly used to reduce pain, anxiety and inflammation. Emerald’s R&D department has spent years studying how CBD works synergistically with other compounds to more effectively deliver these ingredients faster and with great benefit.

The Future Of Liquid Supplements

Emerald has launched a wide selection of branded CBD products infused with herbal supplements. Their product line SMACK’D – THC Control is a CBD oral spray with Black Pepper Oil, Frankincense and Peppermint that was created to control THC induced paranoia. Paranoia and anxiety stemming from consumption of THC products has become a common side effect as new strains of high potency products become available on the market. This lifestyle branded product is supported by thousands of testimonials and it has quickly become one of their flagship products.

As Emerald continues to diversify their offerings, they have ventured into other emerging markets, producing two new flagship product lines that have no CBD or Cannabinoids. +Shrooms (PlusShrooms)
is their response to the exploding functional mushroom market. A line of oil based, flavored mushroom extracts that fuses Mushrooms like Reishi, Chaga and Lion’s Mane with herbal supplements like Raspberry Ketones and Elderberry. Their second venture outside of CBD is with their new line of Apple Cider Vinegar tinctures, Fuji Nutrition. This line combines the almighty Apple Cider Vinegar with a variety of vitamins, herbal ingredients and natural flavoring, to create yet another line of products with a clear first to market advantage.

Follow The Emerald Corp on Instagram and The Emerald Corp on Facebook to stay up to date with company news, new products and promotions.

For questions and interview requests contact:

Ken Key
The Emerald Corp
1-631-246-3414
marketing@theemeraldcorp.com
48 Mall Dr, Commack NY 11725

The post [Press Release] Emerald Corp Is Pioneering The Liquid Supplement Market appeared first on Soliton Solutions PR.

Press Release: Sensabues and RCU Labs Partner to Launch the First Accurate Test for Recent-Use of Cannabis

Soliton Solutions PR — Thu, 05 Mar 2020 12:44:40 +0000

Soliton solutions PR - Tech trade show exhibition specialists

Sensabues breath collection technology integrated into RCU Labs’ Test
to determine recent cannabis use

Stockholm, Sweden and Roseville, California, USA – March 5, 2020: Sensabues AB (“Sensabues”), a leading provider of breath collection technology for detection of drugs, doping and diseases, today announced that it has partnered with RCU Labs, Inc. (“RCU Labs”), a leader in the development of a dual-matrix test for recent cannabis use.

The partnership will see Sensabues and RCU Labs combine their respective technologies to launch the first accurate Recent Cannabis Use Test (“RCU Test”) using breath collection. The new test solves one of the most scientifically elusive issues of the cannabis industry: how to determine whether an impaired driver or employee is under the influence of cannabis.

The RCU Test is the first reliable test method to accurately determine recent cannabis use within the impairment window. The RCU Test is a practical alternative to zero-tolerance and arbitrary tetrahydrocannabinol (THC) drug level policies.

Method
RCU Labs has developed a new pharmacological testing approach based on multiple parameters involving key cannabinoids and Delta9-THC metabolites in blood. The results of the blood test are able to determine recent cannabis use within six hours. To enhance the confidence levels of the RCU Test, RCU Labs has incorporated a second test matrix, exhaled breath, utilizing the patented, low-cost breath collection device from Sensabues. The breath sample can be collected roadside or at an incident site, while the blood sample can be collected at the same time or, if required, up to several hours later. Both the breath and blood samples are then sent to the lab and analyzed using established instrumentation techniques such as high-resolution mass spectrometry for confirmatory data and evidential results. Overall, this dual-matrix approach yielded 100% accuracy within the impairment window following smoking in the first 44 consecutive subjects that have been studied in a clinical trial to date.

Applications
This collaboration seeks to advance the application breakthrough achieved by the RCU Test (patents pending) for law enforcement, workplace drug testing and anti-doping in sport with regard to ease of use and deployment in the field, as well as analytical accuracy in the lab. The RCU Test has obvious applications for law enforcement (roadside DUI collection), for employers investigating workplace incidents (with cause and post-accident situations) and for anti-doping in sport (in-competition testing of athletes and players).

Partnership
Under this agreement, both parties will work to offer a full suite of approved RCU all-in-one and one-time-use test kits together with the validated RCU analytical lab services. Further joint development of RCU Labs’ method is planned to extend the offering to include a definitive recent-use test for other drug groups such as stimulants and performance enhancing drugs.

John Trainor, CEO at Sensabues, said: “RCU Labs has made a major breakthrough with their recent-use test, so Sensabues is delighted to partner with such an innovative US laboratory. The increasing worldwide legalization of medicinal and recreational cannabis use has made zero-tolerance and per se limits policies impractical. The RCU Test offers for the first time a low-cost, standards-based, accurate and objective means of assessing cannabis impairment, whilst avoiding the need for costly field deployable or hand-held equipment.”

Dr. Michael DeGregorio, founder and CEO at RCU Labs, Inc., said: “The Sensabues breath collection technique is a critical addition to our RCU Test. It is the only validated and confirmatory drug testing method available on the commercial market for professional use that is quick, reliable, non-invasive and non-intrusive. Sensabues offers unique, highly differentiating and immediate technical and logistical benefits to the RCU Test. Utilizing both blood and breath testing assures that the test results are accurate while essentially eliminating the possibility of false positives. This partnership with Sensabues enables us to fill a critical unmet need in the drug testing industry.”

###

Notes to Editors

More about Sensabues’ exhaled breath method:

Exhaled breath contains aerosols which originate from lungs and blood. These aerosols contain revealing information for diagnostics, therapeutics and analytics. Sensabues owns the core IP for the design of a simple collection device and the validated methodology to collect, extract and detect the non-volatile substances present within these aerosols using electrostatic filter technology.

This technique is convenient, reliable and low cost. It is a non-invasive way to collect chemicals in breath for disease detection, exposure monitoring, and drug metabolism.

This is a highly sensitive, accurate and confirmatory, back-to-lab based technique, which has been developed into a complete end-to-end analytical platform for use in toxicology, pharmacology and clinical biochemistry that can lead to improved analysis, diagnostics and therapies for medical research, healthcare, law enforcement, criminal justice, schools, workplace drug testing and sports organizations.

About Sensabues AB – Sensabues is a Swedish company with exclusive ownership of a novel method and device to detect non-volatiles in breath. Over 20,000 breath collection devices have been deployed across targeted applications/markets worldwide. There are over 35 technical papers published with data from multiple worldwide studies and large scale field trials by independent third-party labs, institutes, hospitals, clinics, prisons, schools, and sports authorities. To date, over 80 different drugs and compounds have been detected across 25 different categories of substances using this method.
www.sensabues.com

About RCU Labs, Inc. – RCU Labs, Inc., was founded by an established team of eminent scientists, with an extensive background in clinical pharmacology, toxicology and molecular medicine, with the aim of developing new testing approaches to address a number of currently pressing problems facing law enforcement, governing bodies, employers and employees worldwide. RCU Labs, headquartered in Roseville, CA, is accredited to the ISO/IEC 17025 international standard in chemical and forensic testing. The company currently has four patents pending that support the underlying technology behind the RCU Test.
www.rculabs.com

For more information please contact:

John Trainor, Sensabues AB
john.trainor@sensabues.com
+44 (0) 781 808 7755

Humlegårdsgatan 4,114 46, Stockholm,Sweden

www.sensabues.com

Dr Mike DeGregorio
mdegregorio@rculabs.com
+1 (0) 916 771 3114

408 Sunrise Avenue, Roseville, CA 95661, USA

www.rculabs.com

The post Press Release: Sensabues and RCU Labs Partner to Launch the First Accurate Test for Recent-Use of Cannabis appeared first on Soliton Solutions PR.